rs13324
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003873.7(NRP1):c.*1354C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.365 in 152,248 control chromosomes in the GnomAD database, including 11,214 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 11208 hom., cov: 32)
Exomes 𝑓: 0.23 ( 6 hom. )
Consequence
NRP1
NM_003873.7 3_prime_UTR
NM_003873.7 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.458
Publications
9 publications found
Genes affected
NRP1 (HGNC:8004): (neuropilin 1) This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Nov 2020]
NRP1 Gene-Disease associations (from GenCC):
- congenital heart diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.594 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NRP1 | ENST00000374867.7 | c.*1354C>T | 3_prime_UTR_variant | Exon 17 of 17 | 1 | NM_003873.7 | ENSP00000364001.2 | |||
| NRP1 | ENST00000395995.5 | c.*1354C>T | 3_prime_UTR_variant | Exon 16 of 16 | 1 | ENSP00000379317.1 | ||||
| NRP1 | ENST00000374875.5 | c.*1354C>T | 3_prime_UTR_variant | Exon 16 of 16 | 1 | ENSP00000364009.1 | ||||
| NRP1 | ENST00000265371.8 | c.*1354C>T | 3_prime_UTR_variant | Exon 18 of 18 | 5 | ENSP00000265371.3 |
Frequencies
GnomAD3 genomes AF: 0.365 AC: 55494AN: 151848Hom.: 11197 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
55494
AN:
151848
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.232 AC: 65AN: 280Hom.: 6 Cov.: 0 AF XY: 0.247 AC XY: 42AN XY: 170 show subpopulations
GnomAD4 exome
AF:
AC:
65
AN:
280
Hom.:
Cov.:
0
AF XY:
AC XY:
42
AN XY:
170
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
65
AN:
276
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
2
Other (OTH)
AF:
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.365 AC: 55537AN: 151968Hom.: 11208 Cov.: 32 AF XY: 0.362 AC XY: 26895AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
55537
AN:
151968
Hom.:
Cov.:
32
AF XY:
AC XY:
26895
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
22005
AN:
41426
American (AMR)
AF:
AC:
3968
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1095
AN:
3470
East Asian (EAS)
AF:
AC:
3160
AN:
5162
South Asian (SAS)
AF:
AC:
1759
AN:
4820
European-Finnish (FIN)
AF:
AC:
2612
AN:
10556
Middle Eastern (MID)
AF:
AC:
107
AN:
292
European-Non Finnish (NFE)
AF:
AC:
19803
AN:
67956
Other (OTH)
AF:
AC:
790
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1733
3466
5198
6931
8664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1661
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.